Stock H02 HAW PAR CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Haw Par Corporation Limited

Equities

H02

SG1D25001158

Pharmaceuticals

Market Closed - Singapore S.E.
Other stock markets
 05:06:33 2024-04-29 am EDT 		5-day change 1st Jan Change
9.86 SGD +0.41% Intraday chart for Haw Par Corporation Limited +1.44% +1.13%
Apr. 23 Haw Par Corporation Limited Announces Board Appointments CI
Feb. 26 Haw Par Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing of the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. The Company's Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. The Company's Others segment includes property division, which owns and leases out several investment properties in Asia, and leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand products include Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch and Tiger Balm Muscle Rub. Its Kwan Loong brand products include Kwan Loong Medicated and Oil Kwan Loong Refresher.

Number of employees: 595

Sales per Business

SGD in Million2022Weight2023Weight Delta
Healthcare Products
92.0 %
164 90.1 % 213 92.0 % +30.12%
Others
8.0 %
18 9.9 % 19 8.0 % +3.07%

Sales per region

SGD in Million2022Weight2023Weight Delta
Other Asian Countries
36.8 %
60 32.7 % 85 36.8 % +43.39%
Other ASEAN Countries
26.6 %
40 21.8 % 62 26.6 % +56.00%
Other Countries
23.6 %
56 30.6 % 55 23.6 % -1.51%
Singapore
12.9 %
27 14.9 % 30 12.9 % +10.14%

Managers

Managers TitleAgeSince
Ee Lim Wee CEO
 Chief Executive Officer 63 94-03-22
Say Suan Chow DFI
 Director of Finance/CFO 51 99-12-31
Lily Lee Lee Su AUD
 Comptroller/Controller/Auditor - 11-12-31
Peter Chew PRN
 Corporate Officer/Principal - -
Kun Long Chiew SEC
 Corporate Secretary 41 13-12-31

Members of the board

Members of the board TitleAgeSince
Ee Lim Wee CEO
 Chief Executive Officer 63 94-03-22
Ee Chao Wee CHM
 Chairman 71 03-07-07
Sim Ho Ong BRD
 Director/Board Member 55 21-11-09
Weng Keong Low BRD
 Director/Board Member 72 20-06-18
Hiang Meng Gn BRD
 Director/Board Member 70 14-08-12
Choon Soo Chew BRD
 Director/Board Member 67 19-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 221,368,173 135,937,505 ( 61.41 %) 0 61.41 %

Shareholders

NameEquities%Valuation
Wee Family
28.42 %
62,907,926 28.42 % 451 M $
First Eagle Investment Management LLC
10.55 %
23,346,467 10.55 % 167 M $
Kayne Anderson Rudnick Investment Management LLC
5.067 %
11,217,767 5.067 % 80 M $
UNITED OVERSEAS INSURANCE LIMITED
1.931 %
4,274,600 1.931 % 31 M $
Wah Hin & Co. Pte Ltd.
1.650 %
3,652,655 1.650 % 26 M $
C Y Wee & Co. Pte Ltd.
0.7423 %
1,643,148 0.7423 % 12 M $
SG Investments Pte Ltd.
0.7305 %
1,617,000 0.7305 % 12 M $
Estate Of Wee Cho Yaw
0.4935 %
1,092,373 0.4935 % 8 M $
Cheng Song Thia
0.2765 %
612,000 0.2765 % 4 M $
Han Leong Ho
0.2487 %
550,440 0.2487 % 4 M $

Holdings

NameEquities%Valuation
UNITED OVERSEAS BANK LIMITED
2.79%
 47,069,985 2.79% 1,022,244,753 $
UOL GROUP LIMITED
7.97%
 67,354,941 7.97% 286,967,073 $

Company contact information

Haw Par Corp. Ltd.

401 Commonwealth Drive No. 03-03, Haw Par Technocentre

149598, Singapore

+

http://www.hawpar.com
address Haw Par Corporation Limited(H02)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
HAW PAR CORPORATION LIMITED Stock Haw Par Corporation Limited
+1.13% 1.6B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.30% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. H02 Stock
  4. Company Haw Par Corporation Limited